Document Detail


Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study.
MedLine Citation:
PMID:  22829257     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Bisphosphonates (BPs) are used intravenously to treat cancer-related conditions for the prevention of pathological fractures. Osteonecrosis of the jaw (BRONJ) is a rare complication reported in 4-15% of patients. We studied, retrospectively, 55 patients with multiple myeloma or Waldenstrom's macroglobulinemia followed up from different haematological departments who developed BRONJ. All patients were treated with BPs for bone lesions and/or fractures. The most common trigger for BRONJ was dental alveolar surgery. After a median observation of 26 months, no death caused by BRONJ complication was reported. In all, 51 patients were treated with antibiotic therapy, and in 6 patients, this was performed in association with surgical debridement of necrotic bone, in 16 with hyperbaric O(2) therapy/ozonotherapy and curettage and in 12 with sequestrectomy and O(2)/hyperbaric therapy. Complete response was observed in 20 cases, partial response in 21, unchanged in 9 and worsening in 3. The association of surgical treatment with antibiotic therapy seems to be more effective in eradicating the necrotic bone than antibiotic treatment alone. O(2) hyperbaric/ozonotherapy is a very effective treatment. The cumulative dosage of BPs is important for the evolution of BRONJ. Because the most common trigger for BRONJ was dental extractions, all patients, before BP treatment, must achieve an optimal periodontal health.
Authors:
A Andriani; M T Petrucci; T Caravita; M Montanaro; N Villivà; A Levi; A Siniscalchi; V Bongarzoni; F Pisani; M De Muro; U Coppetelli; G Avvisati; A Zullo; A Agrillo; D Gaglioti
Related Documents :
10365547 - Prolactin response to the severity of surgical insult.
15740487 - Dual treatment of albendazole in hepatic hydatidosis: new therapeutic modality in 52 ca...
12186457 - Giant prolactinomas: clinical management and long-term follow up.
12138987 - The association of cushing's disease and primary empty sella turcica.
7227327 - Conservative management of benign oesophageal strictures.
8905107 - Five-year results of conservatively treated tears of the anterior cruciate ligament.
Publication Detail:
Type:  Journal Article     Date:  2012-03-23
Journal Detail:
Title:  Blood cancer journal     Volume:  2     ISSN:  2044-5385     ISO Abbreviation:  Blood Cancer J     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-07-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101568469     Medline TA:  Blood Cancer J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e62     Citation Subset:  -    
Affiliation:
Haematology Unit, P.T.P. Nuovo Regina Margherita, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-posi...
Next Document:  DNA/Polymeric Micelle Self-Assembly Mimicking Chromatin Compaction.